Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection. Issue 13 (26th March 2021)
- Record Type:
- Journal Article
- Title:
- Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection. Issue 13 (26th March 2021)
- Main Title:
- Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection
- Authors:
- Zhang, Yuxiao
Li, Yarong
Chen, Zhiyun
Liu, Xiaoguai
Peng, Xiaokang
He, Qiushui - Abstract:
- Highlights: A CHO cell assay was developed to measure PT neutralizing antibodies (PTNAs). A correlation between serum titers of PTNAs and anti-PT IgG levels was observed. Patients with same level of anti-PT IgG antibodies can have different PTNAs. Determination of PTNAs is important for assessment of functional antibodies. Abstract: Objectives: To determine neutralizing antibodies to pertussis toxin (PTNAs) in children with suspected pertussis and to compare results of PTNAs and anti-PT IgG antibodies. Methods: 172 hospitalized children with suspected pertussis were included. Pertussis was confirmed by culture, PCR and/or serology. PTNAs were determined by Chinese hamster ovary (CHO) cell assay. Results: A correlation between titers of PTNAs and anti-PT IgG levels was noticed in 172 patients (Spearman R = 0.68, P < 0.001). Subjects with same concentrations of anti-PT IgG antibodies could have different titers of PTNAs and the maximum difference observed reached to 1024 times in ELISA-confirmed patients. Moreover, subjects with same titers of PTNAs could have different concentrations of anti-PT IgG antibodies. Conclusions: Our results indicated that in some children high concentrations of anti-PT IgG antibodies do not always mean effective PTNAs induced after infection, stressing the importance of detecting PTNAs after infection and vaccination. Clinical trial registry: Not applicable.
- Is Part Of:
- Vaccine. Volume 39:Issue 13(2021)
- Journal:
- Vaccine
- Issue:
- Volume 39:Issue 13(2021)
- Issue Display:
- Volume 39, Issue 13 (2021)
- Year:
- 2021
- Volume:
- 39
- Issue:
- 13
- Issue Sort Value:
- 2021-0039-0013-0000
- Page Start:
- 1826
- Page End:
- 1830
- Publication Date:
- 2021-03-26
- Subjects:
- Pertussis -- Pertussis toxin neutralizing antibodies -- Anti-PT IgG antibodies -- Children -- China
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2021.02.045 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16023.xml